Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.
Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.
复制标题
DOI:
10.1371/journal.pone.0076104
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Tovanabutra S
中科院分区:
文献类型:
--
作者:
Chenine AL;Wieczorek L;Sanders-Buell E;Wesberry M;Towle T;Pillis DM;Molnar S;McLinden R;Edmonds T;Hirsch I;O'Connell R;McCutchan FE;Montefiori DC;Ochsenbauer C;Kappes JC;Kim JH;Polonis VR;Tovanabutra S
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development of protective HIV-1 vaccines and drugs. These immune assays will be advanced by the development of standardized viral stocks, such as HIV-1 infectious molecular clones (IMC), that i) express a reporter gene, ii) are representative of globally diverse subtypes and iii) are engineered to easily exchange envelope (env) genes for expression of sequences of interest. Thus far, a subtype B IMC backbone expressing Renilla luciferase (LucR), and into which the ectodomain of heterologous env coding sequences can be expressed has been successfully developed but as execution of HIV-1 vaccine efficacy trials shifts increasingly to non-subtype B epidemics (Southern African and Southeast Asia), non-subtype B HIV-1 reagents are needed to support vaccine development. Here we describe two IMCs derived from subtypes C and CRF01_AE HIV-1 primary isolates expressing LucR (IMC.LucR) that were engineered to express heterologous gp160 Envs. 18 constructs expressing various subtypes C and CRF01_AE Envs, mostly acute, in subtype-matched and –unmatched HIV backbones were tested for functionality and neutralization sensitivity. Our results suggest a possible effect of non-env HIV-1 genes on the interaction of Env and neutralizing antibodies and highlight the need to generate a library of IMCs representative of the HIV-1 subtype spectrum to be used as standardized neutralization assay reagents for assessing HIV-1 vaccine efficacy.
登录
查看更多内容
影响因子:
3.7
作者:
Edmonds TG;Ding H;Yuan X;Wei Q;Smith KS;Conway JA;Wieczorek L;Brown B;Polonis V;West JT;Montefiori DC;Kappes JC;Ochsenbauer C
通讯作者:
Ochsenbauer C
DOI:
10.1093/infdis/jis367
发表时间:
2012-08-01
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Montefiori DC;Karnasuta C;Huang Y;Ahmed H;Gilbert P;de Souza MS;McLinden R;Tovanabutra S;Laurence-Chenine A;Sanders-Buell E;Moody MA;Bonsignori M;Ochsenbauer C;Kappes J;Tang H;Greene K;Gao H;LaBranche CC;Andrews C;Polonis VR;Rerks-Ngarm S;Pitisuttithum P;Nitayaphan S;Kaewkungwal J;Self SG;Berman PW;Francis D;Sinangil F;Lee C;Tartaglia J;Robb ML;Haynes BF;Michael NL;Kim JH
通讯作者:
Kim JH
影响因子:
3.8
作者:
Cheung, L;McLain, L;Dimmock, NJ
通讯作者:
Dimmock, NJ
影响因子:
5.4
作者:
Kalia, V;Sarkar, S;Montelaro, RC
通讯作者:
Montelaro, RC
影响因子:
3.8
作者:
Matyas, Gary R.;Wieczorek, Lindsay;Alving, Carl R.
通讯作者:
Alving, Carl R.